Glutamate release through volume-activated channels during spreading depression.

Prior research has shown that astrocytes regulate extracellular glutamate levels through volume-sensitive channels. It was already known that spreading depression (SD) involves cellular swelling and glutamate release. However, the specific pathway through which glutamate is released during SD remained unclear. No prior work had resolved whether synaptic transmission or non-synaptic channels mediate this release. This uncertainty drove the need to distinguish between synaptic and non-synaptic mechanisms of glutamate release during SD. Existing studies suggested a role for NMDA receptors in SD propagation but did not clarify the source of glutamate. The gap motivated investigation into whether volume-activated channels contribute to glutamate release during SD. No prior work had tested the role of volume-sensitive organic anion channels (VSOACs) in this context. This study aimed to address that uncertainty.

The study aimed to determine whether glutamate is released through volume-sensitive organic anion channels (VSOACs) during spreading depression (SD). The researchers focused on the role of VSOACs in glutamate release, independent of synaptic transmission. They examined whether cellular swelling activates these channels and leads to glutamate release. The specific problem addressed was the mechanism of glutamate release during SD in the absence of synaptic activity. The motivation stemmed from the need to distinguish between synaptic and non-synaptic pathways of glutamate release. The authors sought to confirm whether VSOACs mediate glutamate release during SD. They also aimed to test whether NMDA receptor antagonists and VSOAC blockers have similar effects on SD propagation. The study's goal was to clarify the contribution of VSOACs to glutamate release during SD.

The researchers used hippocampal brain slices to induce SD with ouabain. They monitored SD by imaging intrinsic optical signals, which reflect cellular swelling. Glutamate release was measured using high-performance liquid chromatography (HPLC). NMDA receptor antagonists, including MK-801 and CGS-17355, were applied to test their effect on SD propagation. A zero Ca(2+)-EGTA solution was used to suppress synaptic transmission and isolate non-synaptic glutamate release. The VSOAC blocker NPPB was tested for its effect on SD and glutamate release. The study compared the effects of NMDA antagonists and NPPB on SD propagation. HPLC measurements were conducted in both control and zero Ca(2+)-EGTA conditions to assess glutamate release.

The onset of SD was associated with increased light transmittance, indicating cellular swelling. NMDA receptor antagonists reduced the rate of SD propagation, suggesting glutamate involvement. SD occurred in zero Ca(2+)-EGTA solution, showing that synaptic transmission was not required. HPLC measurements confirmed significant glutamate release even in zero Ca(2+)-EGTA solution. NPPB, a VSOAC blocker, also reduced SD propagation similarly to NMDA antagonists. NPPB inhibited glutamate release during SD in zero Ca(2+)-EGTA solution. These findings indicate that VSOACs are activated during SD and mediate glutamate release. The results suggest that VSOACs are a non-synaptic pathway for glutamate release during SD.

The authors concluded that glutamate is released through volume-sensitive organic anion channels (VSOACs) during SD. They proposed that cellular swelling activates VSOACs, leading to glutamate release. The study suggests that this release occurs independently of synaptic transmission. NPPB's effect on SD propagation and glutamate release supports the role of VSOACs. The findings indicate that VSOACs contribute to glutamate release during SD. The authors propose that this mechanism may play a role in excitotoxic damage. They suggest that VSOAC-mediated glutamate release could occur under conditions of cell swelling. The study supports the idea that VSOACs are a significant pathway for glutamate release during SD.